Growing concerns arise as a recent Human Metapneumovirus (HMPV) outbreak in China has been reported. To shed light on the issue, the CDC in China stated that it is killing more people than it had previously, particularly regarding its mortality rate.
According to the CDC, vulnerable groups, such as children, the elderly, and immunocompromised individuals, are more susceptible to contracting the virus, which often coincides with other respiratory infections. “Children, immunocompromised populations, and the elderly are susceptible, and they are more likely to be co-infected with other respiratory viruses. HMPV often causes common cold symptoms, manifested as cough, fever, nasal congestion, and wheezing, but sometimes it can result in bronchitis and pneumonia in severe cases,” the CDC stated.
The agency further cautioned that the severity can be severe in high-risk individuals. “In susceptible individuals with underlying medical conditions, HMPV infection can lead to death. According to data from an article published in *Lancet Global Health* in 2021, one percent of acute lower respiratory infection-related deaths in children under age five can be attributed to HMPV. Currently, there is no vaccine or effective medication against HMPV, and treatment is mostly focused on alleviating symptoms.”
Meanwhile, Dr. Atul Goel, Director-General of Health Services in India, tried to allay public fears about the spread of the virus. He said that the situation is under control and that people should take standard preventive measures. Dr. Goel also said that hospitals are prepared for the seasonal rise in respiratory diseases and that there is no reason to panic at this moment.
Link to article –
HMPV virus in India: What is the death rate in Human Metapneumovirus cases?
